Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.47 |
| ▸ | MDM4 | O15151 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.42 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29401455 | 0.93 | CASP3 (0.50) | CASP3MDM4TP53KMT2APIN1 | |
| SCHEMBL29398070 | 0.93 | CASP3 (0.50) | CASP3MDM4TP53KMT2APIN1 | |
| SCHEMBL30252212 | 0.93 | CASP3 (0.50) | CASP3MDM4TP53KMT2APIN1 | |
| SCHEMBL2367241 | 0.93 | CASP3 (0.50) | CASP3MDM4TP53KMT2APIN1 | |
| SCHEMBL119402 | 0.93 | CASP3 (0.50) | CASP3MDM4TP53KMT2APIN1 | |
| SCHEMBL2366569 | 0.93 | CASP3 (0.50) | CASP3MDM4TP53KMT2APIN1 | |
| SCHEMBL31575313 | 0.93 | CASP3 (0.50) | CASP3MDM4TP53KMT2APIN1 | |
| SCHEMBL2366563 | 0.93 | CASP3 (0.50) | CASP3MDM4TP53KMT2APIN1 | |
| SCHEMBL1738651 | 0.93 | CASP3 (0.50) | CASP3MDM4TP53KMT2APIN1 | |
| SCHEMBL30477937 | 0.93 | CASP3 (0.50) | CASP3MDM4TP53KMT2APIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118005766-B | Solid phase synthesis method of Glepaglutide | 杭州信海医药科技有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118005766-A | Solid phase synthesis method of Glepaglutide | 杭州信海医药科技有限公司 | 2024-05-10 | — | — | CN | disclosed |